Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
nab-paclitaxel versus paclitaxel for advanced urothelial cancer
ACTRN12614001079639Phase 2Completed
- Sponsor
- NHMRC Clinical Trials Centre
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel in transitional cell carcinoma (TCC), sponsored by NHMRC Clinical Trials Centre. Started May 2015; status: completed.
02
Drugs
paclitaxel
03
Conditions
transitional cell carcinoma (TCC)
Beyond the preview
Go deeper on ACTRN12614001079639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614001079639.